Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Franklin

Showing results (571-580 of 606) with videos related to

Pageof 61
Sort By:
Cancer Chemotherapy and Pharmacology|April 26, 2001
Plasma pharmacokinetics and cerebrospinal fluid penetration of thioguanine in children with acute lymphoblastic leukemia: a collaborative Pediatric Oncology Branch, NCI, and Children's Cancer Group studyE S Lowe, B J Kitchen, G Erdmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2003
14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study GroupM Sieber, H Bredenfeld, A Josting, et al.
Bioorganic & Medicinal Chemistry Letters|April 17, 2009
Discovery of 4-azaindoles as novel inhibitors of c-Met kinaseJohn Porter, Simon Lumb, Richard J Franklin, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Peptidomimetic aminomethylene ketone inhibitors of interleukin-1 beta-converting enzyme (ICE)G Semple, D M Ashworth, A R Batt, et al.
Human Mutation|December 3, 2021
Long-read whole genome sequencing reveals HOXD13 alterations in synpolydactylyMarilena Melas, Esko A Kautto, Samuel J Franklin, et al.
Blood|December 9, 1998
Moderate dose escalation for advanced stage Hodgkin's disease using the bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone scheme and adjuvant radiotherapy: a study of the German Hodgkin's Lymphoma Study GroupH Tesch, V Diehl, B Lathan, et al.
Neurology|October 13, 2020
Mexiletine in Myotonic Dystrophy Type 1: A Randomized, Double-Blind, Placebo-Controlled TrialChad Heatwole, Elizabeth Luebbe, Spencer Rosero, et al.
Annals of Emergency Medicine|July 9, 2025
Adoption of Boarding in Inpatient Hallways During Emergency Department CrowdingBrian J Franklin, Sam H Shen, Vikas I Parekh, et al.
Cardiovascular Drugs and Therapy|January 13, 2022
A Multisite Retrospective Review of Direct Oral Anticoagulants Compared to Warfarin in Adult Fontan PatientsAmir Kazerouninia, Justin Georgekutty, Payton Kendsersky, et al.
Antimicrobial Agents and Chemotherapy|September 14, 2011
Phase II dose escalation study of caspofungin for invasive AspergillosisO A Cornely, J J Vehreschild, M J G T Vehreschild, et al.
Pageof 61

Showing results (571-580 of 606) with videos related to

Sort By:
Pageof 61
Cancer Chemotherapy and Pharmacology|April 26, 2001
Plasma pharmacokinetics and cerebrospinal fluid penetration of thioguanine in children with acute lymphoblastic leukemia: a collaborative Pediatric Oncology Branch, NCI, and Children's Cancer Group studyE S Lowe, B J Kitchen, G Erdmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2003
14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study GroupM Sieber, H Bredenfeld, A Josting, et al.
Bioorganic & Medicinal Chemistry Letters|April 17, 2009
Discovery of 4-azaindoles as novel inhibitors of c-Met kinaseJohn Porter, Simon Lumb, Richard J Franklin, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Peptidomimetic aminomethylene ketone inhibitors of interleukin-1 beta-converting enzyme (ICE)G Semple, D M Ashworth, A R Batt, et al.
Human Mutation|December 3, 2021
Long-read whole genome sequencing reveals HOXD13 alterations in synpolydactylyMarilena Melas, Esko A Kautto, Samuel J Franklin, et al.
Blood|December 9, 1998
Moderate dose escalation for advanced stage Hodgkin's disease using the bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone scheme and adjuvant radiotherapy: a study of the German Hodgkin's Lymphoma Study GroupH Tesch, V Diehl, B Lathan, et al.
Neurology|October 13, 2020
Mexiletine in Myotonic Dystrophy Type 1: A Randomized, Double-Blind, Placebo-Controlled TrialChad Heatwole, Elizabeth Luebbe, Spencer Rosero, et al.
Annals of Emergency Medicine|July 9, 2025
Adoption of Boarding in Inpatient Hallways During Emergency Department CrowdingBrian J Franklin, Sam H Shen, Vikas I Parekh, et al.
Cardiovascular Drugs and Therapy|January 13, 2022
A Multisite Retrospective Review of Direct Oral Anticoagulants Compared to Warfarin in Adult Fontan PatientsAmir Kazerouninia, Justin Georgekutty, Payton Kendsersky, et al.
Antimicrobial Agents and Chemotherapy|September 14, 2011
Phase II dose escalation study of caspofungin for invasive AspergillosisO A Cornely, J J Vehreschild, M J G T Vehreschild, et al.
Pageof 61